Abstract
BackgroundInterleukin-12 (IL-12) is a potent activator of anti-tumor immunity, but it’s use as a systemic therapy is limited due to toxicity. MEDI1191 comprises recombinant IL-12 mRNA formulated in lipid nanoparticles...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have